4//SEC Filing
ACCENTIA BIOPHARMACEUTICALS INC 4
Accession 0001181431-07-042303
CIK 0001310094operating
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 1:29 PM ET
Size
9.7 KB
Accession
0001181431-07-042303
Insider Transaction Report
Form 4
Poole William
Director
Transactions
- Award
Stock Option
2007-06-25+6,666→ 20,000 totalExercise: $3.06From: 2007-06-25Exp: 2017-06-24→ Common Stock (6,666 underlying) - Award
Stock Option
2007-06-25+6,667→ 20,000 totalExercise: $3.06From: 2008-06-25Exp: 2017-06-24→ Common Stock (6,667 underlying)
Footnotes (2)
- [F1]Options terminate 10 years from grant date, or 90 days after the non-employee director ceases to be a director for any reason.
- [F2]Exercise price is 100% of fair market value on date of grant.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001310094
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 1:29 PM ET
- Size
- 9.7 KB